Evidence map›Paper›PMID 31489089›Full record

ArticleThe Pan African medical journal2019

High mortality during tuberculosis retreatment at a Ghanaian tertiary center: a retrospective cohort study.

Tara Catherine Bouton, Audrey Forson, Samuel Kudzawu, Francisca Zigah, Helen Jenkins, Tsigereda Danso Bamfo, Jane Carter, Karen Jacobson, Awewura Kwara

Abstract read
In one paragraph

Article in The Pan African medical journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Tara Catherine BoutonDivision of Infectious Diseases, Warren Alpert Medical School, Brown University, Providence, Rhode Island.
Audrey ForsonUniversity of Ghana School of Medicine and Dentistry, Accra, Ghana.
Samuel KudzawuKorle-Bu Teaching Hospital, Accra, Ghana.
Francisca ZigahKorle-Bu Teaching Hospital, Accra, Ghana.
Helen JenkinsDepartment of Biostatistics, Boston University School of Public Health, Boston, Massachusetts.
Tsigereda Danso BamfoKorle-Bu Teaching Hospital, Accra, Ghana.
Jane CarterDivision of Pulmonary, Critical Care and Sleep Medicine, Warren Alpert School of Medicine, Brown University, Providence, Rhode Island.
Karen JacobsonSection of Infectious Diseases, Boston University School of Medicine, Boston, Massachusetts.
Awewura KwaraDivision of Infectious Diseases & Global Medicine, University of Florida College of Medicine, Gainesville, Florida.

Funding

Translational ScienceP30AI042853 · NIAID · MIRIAM HOSPITAL · PI LARRY K BROWN · 1998 to 2026
$51.7M
HIV and Other Infectious Consequences of Substance UseT32DA013911 · NIDA · MIRIAM HOSPITAL · PI TRACI C GREEN, JOSIAH D RICH · 2001 to 2026
$9.6M
NIAID NIH HHS P30 AI042853NIDA NIH HHS T32 DA013911
6 · The paper itself

Abstract

introductionHigh mortality among individuals receiving retreatment for tuberculosis (RT-TB) persists, although reasons for these poor outcomes remain unclear.

methodsWe retrospectively reviewed 394 RT-TB patients diagnosed between January 2010 and June 2016 in Accra, Ghana.

resultsOf RT-TB patients, 161 (40.9%) were treated empirically (negative/absent smear, culture or Xpert), of whom 30.4% (49/161) had only extrapulmonary TB signs or symptoms. Mortality during treatment was 19.4%; 15-day mortality was 10.8%. In multivariable proportional hazards regression, living with HIV (aHR=2.69 [95 CI: 1.51, 4.80], p<0.01) and previous loss-to-follow up (aHR=8.27 (95 CI: 1.10, 62.25), p=0.04) were associated with mortality, while drug susceptibility testing (DST, aHR=0.36 (95 CI: 0.13, 1.01), p=0.052) was protective. Isoniazid resistance was observed in 40% (23/58 tested) and rifampin resistance in 19.1% (12/63 tested).

conclusionHigh rates of extrapulmonary TB and smear/culture negative disease highlight the barriers to achieving DST-driven RT-TB regimens and the need for improved diagnostics. Our finding of poly-drug resistance in rifampin-susceptible cases supports access to comprehensive first line DST. Additionally, interventions to reduce mortality, especially in HIV co-infected RT-TB patients, are urgently needed.

Indexed as

AdultAntitubercular AgentsCohort StudiesDrug Resistance, Multiple, BacterialFemaleGhanaHIV InfectionsHumansIsoniazidMaleMicrobial Sensitivity TestsMiddle AgedMultivariate AnalysisMycobacterium tuberculosisProportional Hazards ModelsRetreatmentAntitubercular AgentsIsoniazidRifampindrug resistant tuberculosispreviously treated tuberculosisRecurrent tuberculosis

Identifiers

PMID31489089
PMCPMC6711700

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.